ICD-10-CM & ICD-10-PCS (2021)-ICD-10-CM: Diseases and Injuries (2021)-ICD-10-CM: Drugs and Chemicals (2021)-ICD-10-CM: External Cause of Injuries (2021)-ICD-10-PCS (2021)ICD-10-CM & ICD-10-PCS (2020)-ICD-10-CM: Diseases and Injuries (2020)-ICD-10-CM: Drugs and Chemicals (2020)-ICD-10-CM: External Cause of Injuries (2020)-ICD-10-PCS (2020)ICD-10-CM & ICD-10-PCS (2019)-ICD-10-CM: Diseases and Injuries (2019)-ICD-10-CM: Drugs and Chemicals (2019)-ICD-10-CM: External Cause of Injuries (2019)-ICD-10-PCS (2019)ICD-10-CM & ICD-10-PCS (2018)-ICD-10-CM: Diseases and Injuries (2018)-ICD-10-CM: Drugs and Chemicals (2018)-ICD-10-CM: External Cause of Injuries (2018)-ICD-10-PCS (2018)ICD-10-CM & ICD-10-PCS (2017)-ICD-10-CM: Diseases and Injuries (2017)-ICD-10-CM: Drugs and Chemicals (2017)-ICD-10-CM: External Cause of Injuries (2017)-ICD-10-PCS (2017)ICD-10-CM & ICD-10-PCS (2016)-ICD-10-CM: Diseases and Injuries (2016)-ICD-10-CM: Drugs and Chemicals (2016)-ICD-10-CM: External Cause of Injuries (2016)-ICD-10-PCS (2016) Create codetable from scratch     Show conversion to ICD-9-CM     Contact

Carcinoma (malignant) --see also Neoplasm, by site, malignant
    acidophil
        specified site --see Neoplasm, malignant, by site
        unspecified site C75.1
    acidophil-basophil, mixed
        specified site --see Neoplasm, malignant, by site
        unspecified site C75.1
    adnexal (skin) --see Neoplasm, skin, malignant
    adrenal cortical C74.0-
    alveolar --see Neoplasm, lung, malignant
        cell --see Neoplasm, lung, malignant
    ameloblastic C41.1
        upper jaw (bone) C41.0
    apocrine
        breast --see Neoplasm, breast, malignant
        specified site NEC --see Neoplasm, skin, malignant
        unspecified site C44.99
    basal cell (pigmented) (see also Neoplasm, skin, malignant) C44.91
        fibro-epithelial --see Neoplasm, skin, malignant
        morphea --see Neoplasm, skin, malignant
        multicentric --see Neoplasm, skin, malignant
    basaloid
    basal-squamous cell, mixed --see Neoplasm, skin, malignant
    basophil
        specified site --see Neoplasm, malignant, by site
        unspecified site C75.1
    basophil-acidophil, mixed
        specified site --see Neoplasm, malignant, by site
        unspecified site C75.1
    basosquamous --see Neoplasm, skin, malignant
    bile duct
        with hepatocellular, mixed C22.0
        liver C22.1
        specified site NEC --see Neoplasm, malignant, by site
        unspecified site C22.1
    branchial or branchiogenic C10.4
    bronchial or bronchogenic --see Neoplasm, lung, malignant
    bronchiolar --see Neoplasm, lung, malignant
    bronchioloalveolar --see Neoplasm, lung, malignant
    C cell
        specified site --see Neoplasm, malignant, by site
        unspecified site C73
    ceruminous C44.29-
    cervix uteri
        in situ D06.9
            endocervix D06.0
            exocervix D06.1
            specified site NEC D06.7
    chorionic
        specified site --see Neoplasm, malignant, by site
        unspecified site
            female C58
            male C62.90
    chromophobe
        specified site --see Neoplasm, malignant, by site
        unspecified site C75.1
    cloacogenic
        specified site --see Neoplasm, malignant, by site
        unspecified site C21.2
    diffuse type
        specified site --see Neoplasm, malignant, by site
        unspecified site C16.9
    duct (cell)
        with Paget's disease --see Neoplasm, breast, malignant
        infiltrating
            with lobular carcinoma (in situ)
                specified site --see Neoplasm, malignant, by site
                unspecified site (female) C50.91-
                    male C50.92-
            specified site --see Neoplasm, malignant, by site
                unspecified site (female) C50.91-
                    male C50.92-
    ductal
        with lobular
            specified site --see Neoplasm, malignant, by site
            unspecified site (female) C50.91-
                male C50.92-
    ductular, infiltrating
        specified site --see Neoplasm, malignant, by site
        unspecified site (female) C50.91-
            male C50.92-
    embryonal
        liver C22.7
    endometrioid
        specified site --see Neoplasm, malignant, by site
        unspecified site
            female C56.9
            male C61
    eosinophil
        specified site --see Neoplasm, malignant, by site
        unspecified site C75.1
    epidermoid --see also Neoplasm, skin malignant
        in situ, Bowen's type --see Neoplasm, skin, in situ
    fibroepithelial, basal cell --see Neoplasm, skin, malignant
    follicular
        with papillary (mixed) C73
        moderately differentiated C73
        pure follicle C73
        specified site --see Neoplasm, malignant, by site
        trabecular C73
        unspecified site C73
        well differentiated C73
    generalized, with unspecified primary site C80.0
    glycogen-rich --see Neoplasm, breast, malignant
    granulosa cell C56-
    hepatic cell C22.0
    hepatocellular C22.0
        with bile duct, mixed C22.0
        fibrolamellar C22.0
    hepatocholangiolitic C22.0
    Hurthle cell C73
    in
        adenomatous
            polyposis coli C18.9
        pleomorphic adenoma --see Neoplasm, salivary glands, malignant
        situ --see Carcinoma-in-situ
    infiltrating
        duct
            with lobular
                specified site --see Neoplasm, malignant, by site
                unspecified site (female) C50.91-
                    male C50.92-
            with Paget's disease --see Neoplasm, breast, malignant
            specified site --see Neoplasm, malignant
            unspecified site (female) C50.91-
                male C50.92-
        ductular
            specified site --see Neoplasm, malignant
            unspecified site (female) C50.91-
                male C50.92-
        lobular
            specified site --see Neoplasm, malignant
            unspecified site (female) C50.91-
                male C50.92-
    inflammatory
        specified site --see Neoplasm, malignant
        unspecified site (female) C50.91-
            male C50.92-
    intestinal type
        specified site --see Neoplasm, malignant, by site
        unspecified site C16.9
    intracystic
        noninfiltrating --see Neoplasm, in situ, by site
    intraductal (noninfiltrating)
        with Paget's disease --see Neoplasm, breast, malignant
        breast D05.1-
        papillary
            with invasion
                specified site --see Neoplasm, malignant, by site
                unspecified site (female) C50.91-
                    male C50.92-
            breast D05.1-
            specified site NEC --see Neoplasm, in situ, by site
            unspecified site (female) D05.1-
        specified site NEC --see Neoplasm, in situ, by site
        unspecified site (female) D05.1-
    intraepidermal --see Neoplasm, in situ
        squamous cell, Bowen's type --see Neoplasm, skin, in situ
    intraepithelial --see Neoplasm, in situ, by site
        squamous cell --see Neoplasm, in situ, by site
    intraosseous C41.1
        upper jaw (bone) C41.0
    islet cell
        with exocrine, mixed
            specified site --see Neoplasm, malignant, by site
            unspecified site C25.9
        pancreas C25.4
        specified site NEC --see Neoplasm, malignant, by site
        unspecified site C25.4
    juvenile, breast --see Neoplasm, breast, malignant
    large cell
        small cell
            specified site --see Neoplasm, malignant, by site
            unspecified site C34.90
    Leydig cell (testis)
        specified site --see Neoplasm, malignant, by site
        unspecified site
            female C56.9
            male C62.90
    lipid-rich (female) C50.91-
        male C50.92-
    liver cell C22.0
    liver NEC C22.7
    lobular (infiltrating)
        with intraductal
            specified site --see Neoplasm, malignant, by site
            unspecified site (female) C50.91-
                male C50.92-
        noninfiltrating
            breast D05.0-
            specified site NEC --see Neoplasm, in situ, by site
            unspecified site D05.0-
        specified site --see Neoplasm, malignant, by site
        unspecified site (female) C50.91-
            male C50.92-
    medullary
        with
            amyloid stroma
                specified site --see Neoplasm, malignant, by site
                unspecified site C73
            lymphoid stroma
                specified site --see Neoplasm, malignant, by site
                unspecified site (female) C50.91-
                    male C50.92-
    Merkel cell C4A.9
        anal margin C4A.51
        anal skin C4A.51
        canthus C4A.1-
        ear and external auricular canal C4A.2-
        external auricular canal C4A.2-
        eyelid, including canthus C4A.1-
        face C4A.30
            specified NEC C4A.39
        hip C4A.7-
        lip C4A.0
        lower limb, including hip C4A.7-
        neck C4A.4
        nodal presentation C7B.1
        nose C4A.31
        overlapping sites C4A.8
        perianal skin C4A.51
        scalp C4A.4
        secondary C7B.1
        shoulder C4A.6-
        skin of breast C4A.52
        trunk NEC C4A.59
        upper limb, including shoulder C4A.6-
        visceral metastatic C7B.1
    metastatic --see Neoplasm, secondary, by site
    metatypical --see Neoplasm, skin, malignant
    morphea, basal cell --see Neoplasm, skin, malignant
    mucoid
        cell
            specified site --see Neoplasm, malignant, by site
            unspecified site C75.1
    neuroendocrine --see also Tumor, neuroendocrine
        high grade, any site C7A.1
        poorly differentiated, any site C7A.1
    nonencapsulated sclerosing C73
    noninfiltrating
        intracystic --see Neoplasm, in situ, by site
        intraductal
            breast D05.1-
            papillary
                breast D05.1-
                specified site NEC --see Neoplasm, in situ, by site
                unspecified site D05.1-
            specified site --see Neoplasm, in situ, by site
            unspecified site D05.1-
        lobular
            breast D05.0-
            specified site NEC --see Neoplasm, in situ, by site
            unspecified site (female) D05.0-
    oat cell
        specified site --see Neoplasm, malignant, by site
        unspecified site C34.90
    odontogenic C41.1
        upper jaw (bone) C41.0
    papillary
        with follicular (mixed) C73
        follicular variant C73
        intraductal (noninfiltrating)
            with invasion
                specified site --see Neoplasm, malignant, by site
                unspecified site (female) C50.91-
                    male C50.92-
            breast D05.1-
            specified site NEC --see Neoplasm, in situ, by site
            unspecified site D05.1-
        serous
            specified site --see Neoplasm, malignant, by site
            surface
                specified site --see Neoplasm, malignant, by site
                unspecified site C56.9
            unspecified site C56.9
    papillocystic
        specified site --see Neoplasm, malignant, by site
        unspecified site C56.9
    parafollicular cell
        specified site --see Neoplasm, malignant, by site
        unspecified site C73
    pilomatrix --see Neoplasm, skin, malignant
    pseudomucinous
        specified site --see Neoplasm, malignant, by site
        unspecified site C56.9
    renal cell C64-
    Schmincke --see Neoplasm, nasopharynx, malignant
    Schneiderian
        specified site --see Neoplasm, malignant, by site
        unspecified site C30.0
    sebaceous --see Neoplasm, skin, malignant
    secondary --see also Neoplasm, secondary, by site
        Merkel cell C7B.1
    secretory, breast --see Neoplasm, breast, malignant
    serous
        papillary
            specified site --see Neoplasm, malignant, by site
            unspecified site C56.9
        surface, papillary
            specified site --see Neoplasm, malignant, by site
            unspecified site C56.9
    Sertoli cell
        specified site --see Neoplasm, malignant, by site
        unspecified site C62.90
            female C56.9
            male C62.90
    skin appendage --see Neoplasm, skin, malignant
    small cell
        fusiform cell
            specified site --see Neoplasm, malignant, by site
            unspecified site C34.90
        intermediate cell
            specified site --see Neoplasm, malignant, by site
            unspecified site C34.90
        large cell
            specified site --see Neoplasm, malignant, by site
            unspecified site C34.90
    solid
        with amyloid stroma
            specified site --see Neoplasm, malignant, by site
            unspecified site C73
        microinvasive
            specified site --see Neoplasm, malignant, by site
            unspecified site C53.9
    sweat gland --see Neoplasm, skin, malignant
    theca cell C56.-
    thymic C37
    unspecified site (primary) C80.1
    water-clear cell C75.0